Outcomes Study: Impact of PROMIS-10 on Health-Related Quality-of-Life Outcomes in Specialty Pharmacy Settings

All Posts

Outcomes Study: Impact of PROMIS-10 on Health-Related Quality-of-Life Outcomes in Specialty Pharmacy Settings


Members of our team had the opportunity to present a new poster abstract at the  2023 NASP Annual Meeting & Expo, which was held from September 18-21. 

PROMIS-10 HRQoL

Background

  • Specialty pharmacy (SP) accreditation standards frequently highlight the importance of establishing performance systems to evaluate patient outcomes.
  • Among the various tools available, the Patient-Reported Outcomes Measurement Information System-10 (PROMIS-10) stands out as a concise, extensively utilized, and validated ten-item questionnaire.
  • PROMIS-10 is designed to evaluate health-related quality-of-life (HRQoL) measures that assess both the physical and mental health status of patients.
  • SPs are uniquely positioned to intervene when patients report low or worsening HRQoL measures; however, the impact of PROMIS-10 measures in SP settings is not well documented.

Objectives

To determine the impact of implementing PROMIS-10 in SP settings utilizing the TherigySTM℠ platform, a clinical care management and reporting technology, to document patient HRQoL outcomes and associated interventions.

 

Read about the team's findings by downloading the Outcomes Study below.

 

Download the abstract:

 

Submit your contact information below to receive insights from our team of pharmacy solutions experts.